: A high-beta tech play that gained 109% due to a surge in demand and pricing for memory chips used in mobile devices and servers. Sector-Specific Risk Profiles
: Nine of the top ten performing stocks of the year were in the biotech sector. Companies like Vertex Pharmaceuticals (VRTX) (up 97%) and Dynavax Technologies (DVAX) (up 373%) succeeded based on FDA approvals and breakthrough trial data. high risk stocks to buy 2017
: Despite a "chaotic news cycle," markets remained remarkably steady, allowing growth premiums to outperform value premiums significantly. : A high-beta tech play that gained 109%